03.03.17
Johnson & Johnson Consumer Inc. is presenting 21 Posters/Abstracts at this year's American Academy of Dermatology (AAD) Annual Meeting in Orlando, FL, on March 3rd - 7th, 2017.
The research includes studies in photoprotection, light therapy for acne, atopic dermatitis and skin microbiome. Scientific Posters include evaluations of high-SPF sunscreen in real-world settings, as well as an assessment of efficacy, tolerance and mode of action for low-level blue/red light therapy in treatment of acne.
All abstracts will be available for online viewing at the AAD meeting starting today, from 7:00 a.m. EST on March 3, 2017.
"As the research shared at this meeting shows, our scientists study skin health around the world and across a lifetime, from birth to maturity," said Jennifer Zhu, Vice President, Global Beauty R&D at Johnson & Johnson Consumer Inc. "We are committed to developing transformative solutions for common skincare concerns, while adhering to a high standard of clinical efficacy and superior aesthetics."
The research includes studies in photoprotection, light therapy for acne, atopic dermatitis and skin microbiome. Scientific Posters include evaluations of high-SPF sunscreen in real-world settings, as well as an assessment of efficacy, tolerance and mode of action for low-level blue/red light therapy in treatment of acne.
All abstracts will be available for online viewing at the AAD meeting starting today, from 7:00 a.m. EST on March 3, 2017.
"As the research shared at this meeting shows, our scientists study skin health around the world and across a lifetime, from birth to maturity," said Jennifer Zhu, Vice President, Global Beauty R&D at Johnson & Johnson Consumer Inc. "We are committed to developing transformative solutions for common skincare concerns, while adhering to a high standard of clinical efficacy and superior aesthetics."
